Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Illinois › Cicero
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Cicero, IL keessatti
Qorannoo 24 Kansara Qara'a Non-Small Cell f Cicero fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · Miili 10 fagaatti
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
- Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern Medicine Oak Brook, Oak Brook · Miili 9 fagaatti
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Hope and Healing Cancer Services, Hinsdale · Miili 10 fagaatti
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Namoota walitti qabaa jiraSadarkaa 3
- Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
- Hope and Healing Cancer Services, Hinsdale · Miili 10 fagaatti
- Endeavor Health, Elmhurst · Miili 10 fagaatti
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Namoota walitti qabaa jiraSadarkaa 2
- Hope and Healing Clinical Research, Hinsdale · Miili 10 fagaatti
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Hinsdale · Miili 10 fagaatti
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Namoota walitti qabaa jiraSadarkaa 3
- Affiliated Oncologists, LLC, Chicago Ridge · Miili 10 fagaatti
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Hinsdale · Miili 10 fagaatti
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- Loyola University Medical Center, Maywood · Miili 5 fagaatti
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Hope and Healing Cancer Services, Hinsdale · Miili 10 fagaatti
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Affiliated Oncologists, LLC, Chicago Ridge · Miili 10 fagaatti
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Hinsdale · Miili 10 fagaatti
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Hinsdale · Miili 10 fagaatti
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern Medicine Oak Brook, Oak Brook · Miili 9 fagaatti
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · Miili 10 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · Miili 3 fagaatti
- Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
- Loyola University Medical Center, Maywood · Miili 5 fagaatti
- fi 2 dabalataa
MYLUNG Consortium Part 3: Observational Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Affiliated Oncologists, LLC, Chicago Ridge · Miili 10 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
- Loyola University Medical Center, Maywood · Miili 5 fagaatti
- Northwestern Medicine Oak Brook, Oak Brook · Miili 9 fagaatti
- fi 3 dabalataa
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Loyola University Medical Center, Maywood · Miili 5 fagaatti
- Northwestern Medicine Oak Brook, Oak Brook · Miili 9 fagaatti
- Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
- fi 2 dabalataa
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Edward Hines Jr VA Hospital, Hines · Miili 4 fagaatti
- Loyola University Medical Center, Maywood · Miili 5 fagaatti
- Northwestern Medicine Oak Brook, Oak Brook · Miili 9 fagaatti
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Advocate Christ Medical Center, Oak Lawn · Miili 9 fagaatti
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · Miili 9 fagaatti
- Advocate High Tech Medical Park, Palos Heights · Miili 12 fagaatti
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Namoota walitti qabaa jira
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · Miili 4 fagaatti
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Hope and Healing Cancer Services, Hinsdale · Miili 10 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Cicero keessatti
- Dhibee QaraQorannoo 17
- Kansarii ProstateQorannoo 14
- Saree (Gosoota Hunda)Qorannoo 13
- Saree OljooQorannoo 11
- Leukemia Myeloidii HamaaQorannoo 11
- Kansarii ColorectalQorannoo 10
- Dukkana BladderQorannoo 8
- MelanomaQorannoo 7
- Dhibee Onneessaa fi DhiigaQorannoo 7
- Kansara MetastatikiiQorannoo 7
- Myeloma Baay’eeQorannoo 6
- Burkitt LymphomaQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.